Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosslyn Data Regulatory News (RDT)

Share Price Information for Rosslyn Data (RDT)

Share Price is delayed by 15 minutes
Get Live Data
1.85    0.00 (0.00%)
Bid:
1.80
Ask:
1.90
Spread: 0.10 (5.556%)
Market Cap: £2.18m
RDT Live PriceLast checked at - London Stock Exchange

Intraday Rosslyn Data Share Chart

Board Changes

14 Mar 2025 07:00

RNS Number : 6440A
Rosslyn Data Technologies PLC
14 March 2025
 

14 March 2025

 

Rosslyn Data Technologies plc

("Rosslyn", the "Group" or the "Company")

 

Board Changes

 

Rosslyn (AIM: RDT), the provider of a leading cloud-based enterprise spend intelligence platform, is pleased to announce the appointment of Dr John Chessher as an Independent Non-Executive Director with immediate effect. John will replace Ginny Warr who has informed the Company of her decision to step down as a Non-Executive Director of the Company due to increased commitments in her executive role. Ginny will step down from the Board on 31 March 2025.

 

John has 30 years' investment industry experience and has held CEO and director-level positions at leading asset management and investment banking firms. He has most notably previously acted as CEO of Cenkos Securities Asia and as Head of Asia Pacific Research at Schroder Investment Management. John is currently a Non-Executive Director of Sunda Energy plc, an AIM-listed exploration and appraisal company focussed on gas assets in Southeast Asia.

 

John is a CFA charter-holder, holds an MA in Engineering Science from Oxford University and DBA, MSc and MBA qualifications from Henley Business School.

 

Following his appointment, John will act as Chair of the Audit and Remuneration Committees.

 

James Appleby, Chairman of Rosslyn, said: "I am delighted to welcome John to the Board of Rosslyn. We look forward to working with him and benefitting from his significant corporate experience. I would also like to thank Ginny for her excellent contribution over the past few years and we wish her well for the future."

 

Enquiries

 

Rosslyn

Paul Watts, Chief Executive Officer

James Appleby, Chairman

+44 (0)20 3285 8008

 

Cavendish Capital Markets Limited (Nominated adviser and Broker)

Stephen Keys/Camilla Hume/George Lawson

+44 (0)20 7220 0500

Gracechurch Group (Financial PR)

Claire Norbury/Anysia Virdi

+44 (0)20 4582 3500

 

 

Further information on Dr John Chessher

 

John Robert Chessher (aged 62) has held the following directorships in the past 5 years:

 

Current Directorships

Previous Directorships held in the past 5 years

Sunda Energy plc

Mind Markets Limited

 

Dr John Chessher does not own any ordinary shares or options over ordinary shares in the Company.

 

There is no further information on Dr John Chessher required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

About Rosslyn

 

Rosslyn (AIM: RDT) provides an award-winning spend intelligence platform. The Rosslyn Platform helps organizations with diverse supply chains mitigate risk and make informed strategic decisions. It leverages automated workflows, artificial intelligence and machine learning to extract and consolidate procurement data providing visibility of complex supplier data, enabling supplier spend savings and delivering rapid ROI. For more information visit www.rosslyn.ai. Investors wishing to contact the Company should email investors@rosslyn.ai.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKNBPCBKDDND
Date   Source Headline
5th Sep 20235:02 pmRNSResult of Retail Offer
31st Aug 20237:00 amRNSResult of Placing and Posting of Circular
30th Aug 20234:35 pmRNSRetail Offer
30th Aug 20234:30 pmRNSProposed Placing, Loan Note Issue & Notice of GM
30th May 20237:00 amRNSRosslyn wins two new contracts
11th Apr 20234:40 pmRNSHolding(s) in Company
6th Apr 20237:00 amRNSTrading Update
9th Mar 20239:48 amRNSHolding(s) in Company
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
31st Jan 20239:05 amRNSSecond Price Monitoring Extn
31st Jan 20239:00 amRNSPrice Monitoring Extension
30th Jan 20234:40 pmRNSSecond Price Monitoring Extn
30th Jan 20234:35 pmRNSPrice Monitoring Extension
30th Jan 20232:05 pmRNSSecond Price Monitoring Extn
30th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Jan 202311:05 amRNSSecond Price Monitoring Extn
30th Jan 202311:00 amRNSPrice Monitoring Extension
30th Jan 20237:00 amRNSRosslyn wins new multi-year contract
30th Jan 20237:00 amRNSInterim Results
12th Jan 20235:24 pmRNSHolding(s) in Company
14th Dec 20224:16 pmRNSGrant of Options
6th Dec 20221:37 pmRNSResult of Annual General Meeting
11th Nov 20224:24 pmRNSNotice of Annual General Meeting
7th Nov 20227:00 amRNSTwo Contract Wins
1st Nov 202211:06 amRNSSecond Price Monitoring Extn
1st Nov 202211:02 amRNSSale of Integritie
1st Nov 202211:00 amRNSPrice Monitoring Extension
31st Oct 20224:51 pmRNSPublication of Annual Report
31st Oct 20223:07 pmRNSFinal Results
10th Oct 20224:41 pmRNSSecond Price Monitoring Extn
10th Oct 20224:36 pmRNSPrice Monitoring Extension
3rd Oct 20227:00 amRNSSale of Langdon Systems
29th Sep 20227:00 amRNSRosslyn wins £500k contract
22nd Aug 20227:00 amRNSFirst contract secured with Chain IQ
2nd Aug 20222:30 pmRNSInvestor Webinar
29th Jun 20227:00 amRNSBusiness Update
31st Jan 20227:00 amRNSHalf-year Report
14th Jan 20229:05 amRNSSecond Price Monitoring Extn
14th Jan 20229:00 amRNSPrice Monitoring Extension
13th Jan 20227:00 amRNSTrading Statement
28th Oct 20214:15 pmRNSResult of AGM
4th Oct 20219:34 amRNSAnnual Report and AGM Notice
30th Sep 20217:00 amRNSFinal Results
13th Sep 20211:59 pmRNSHolding(s) in Company
16th Aug 202111:27 amRNSGrant of Options
5th Jul 20217:00 amRNSDirectorate Change
4th Jun 20217:00 amRNSBoard Change
4th Jun 20217:00 amRNSTrading Update
6th Apr 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.